Picard Medical, Inc.
Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart…
1D
+27.5%
1W
+34.5%
1M
+96.8%
6M
-72.5%
YTD
-85.4%
1Y
-97.5%
2Y
–
5Y
–
10Y
–
Next earnings date
13/11/2026 (in 27 days)
Volatility around earnings
~25% weaker price swings than usual
0
STRONG BUY
0
BUY
1
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Hold
As of: 03/06/2026
P/E
-0.62
P/B
13.79
EV/EBITDA
-54.48
RETURN ON EQUITY
-329.8%
NET MARGIN
-191.6%
DEBT/EQUITY
0.51
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
38.5%
FLOAT SHARES
39,507,264
AVG. DAILY VOLUME (30D)
438,086
Picard Medical, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Richard Fang, the company employs around 75 people.
The IPO was on 29/08/2025; the stock trades on AMEX under the ticker PMI.
1 analysts rate the stock, the consensus is Hold (as of 03/06/2026).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 13/11/2026.
Around past earnings, price swings were roughly -25% stronger than usual.
No, Picard Medical currently does not pay a dividend.
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
Clicking "Analyze stock" lets five strategies assess Picard Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.